Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2024

    

2023

    

2024

    

2023

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

309,933

$

89,172

$

453,158

$

227,896

General and administrative

 

1,224,121

 

408,706

 

2,334,508

 

1,097,945

Total stock-based compensation

$

1,534,054

$

497,878

$

2,787,666

$

1,325,841